GSK to Cease Production Indian API Plant

GSK tells in-Pharmatechnologist.com that decision to close Indian API plant was prompted by rising cost of manufacture and availability of third party contractors.
Aug. 23, 2012
Sign up for our eNewsletters
Get the latest news and updates